Cabinet Health launched its refillable mail-order prescription solution. Cabinet Health Rx is a direct-to-consumer healthcare service dedicated to improving the pharmacy patient experience and the environmental impact of the pharmaceutical industry.
Determining whether a person is diabetic could be as easy as having them speak a few sentences into their smartphone, according to a groundbreaking study from Klick Labs that combines voice technology with artificial intelligence in a major step forward in diabetes detection.
CIONIC, the pioneering neurotech company that created the FDA-cleared Cionic Neural Sleeve, today announced an additional $12 million extension of its Series A financing, bringing the Series A total to $25 million.
Evidation, the company creating new ways to measure and improve health in everyday life, today announced that it has been awarded a contract by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services (HHS), to fund the 2023 Influenza-like Illness (ILI) Detect & Protect Studies.
Evident Vascular, Inc., a medical technology startup developing a next-generation intravascular ultrasound (IVUS) platform leveraging artificial intelligence to enable superior imaging and streamlined workflows, announced today that it has launched with a $35 million Series A financing from Vensana Capital®.
Great Speech, a leader in virtual speech therapy, announces the expansion of its in-network services to serve the TRICARE West Region population through Health Net Federal Services, LLC, (HNFS).
Baxter International Inc. (NYSE:BAX), a leader in patient monitoring, physical assessment and vision screening products, announced the launch of digital image capture capability for eye exams using its existing Welch Allyn PanOptic Plus Ophthalmoscope.
Better Therapeutics, Inc. (NASDAQ: BTTX), a pioneer in developing prescription digital therapeutics (PDTs) to treat cardiometabolic diseases, today announced the commercial launch of AspyreRx, the first cognitive behavioral therapy (CBT) app to receive U.S Food and Drug Administration (FDA) authorization as a Class II device to treat adults with type 2 diabetes (T2D).
FINEOS, the leading modern enterprise core software for the life, accident and health industry, has forged a partnership with Osara Health, a digital health platform founded by oncologists, to enhance the care experience for individuals dealing with cancer.
BIOQuébec and BioFlorida, preeminent life sciences associations from Québec and Florida, are proud to announce the signing of a Memorandum of Understanding (MOU).